Menu
Back to Archived Journals » Core Evidence
Core Evidence ceased publishing in March 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Journal Articles:
- 143 records -
Riociguat in the Treatment of Chronic Thromboembolic Pulmonary Hypertension: An Evidence-Based Review of Its Place in Therapy
Donaldson S, Ogunti R, Kibreab A, Mehari A
Core Evidence 2020, 15:31-40
Published Date: 25 August 2020
Management of Chemotherapy-Induced Nausea and Vomiting (CINV): A Short Review on the Role of Netupitant-Palonosetron (NEPA)
Lorusso V, Russo A, Giotta F, Codega P
Core Evidence 2020, 15:21-29
Published Date: 27 July 2020
Vedolizumab in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Safety, Efficacy, and Place of Therapy
Takatsu N, Hisabe T, Higashi D, Ueki T, Matsui T
Core Evidence 2020, 15:7-20
Published Date: 1 April 2020
Apixaban: An Update of the Evidence for Its Place in the Prevention of Stroke in Patients with Atrial Fibrillation
Seeger J, Wöhrle J
Core Evidence 2020, 15:1-6
Published Date: 21 January 2020
Pertuzumab in the treatment of HER2-positive breast cancer: an evidence-based review of its safety, efficacy, and place in therapy
Ishii K, Morii N, Yamashiro H
Core Evidence 2019, 14:51-70
Published Date: 31 October 2019
Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy
Taylor AD, Saag KG
Core Evidence 2019, 14:41-50
Published Date: 23 August 2019
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy
Bassetti M, Castaldo N, Carnelutti A, Peghin M, Giacobbe DR
Core Evidence 2019, 14:31-40
Published Date: 5 July 2019
Lomitapide: a review of its clinical use, efficacy, and tolerability
Alonso R, Cuevas A, Mata P
Core Evidence 2019, 14:19-30
Published Date: 1 July 2019
Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy
Galkin M, Jonas BA
Core Evidence 2019, 14:3-17
Published Date: 26 April 2019
Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review [Erratum]
Beccari MV, Meaney CJ
Core Evidence 2019, 14:1-2
Published Date: 27 February 2019
Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy
Lattanzi S, Brigo F, Cagnetti C, Verrotti A, Zaccara G, Silvestrini M
Core Evidence 2018, 13:21-31
Published Date: 8 March 2018
Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
Eshtiaghi P, Gooderham MJ
Core Evidence 2018, 13:13-20
Published Date: 23 February 2018
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in therapy
Brousell SC, Fantony JJ, Van Noord MG, Harrison MR, Inman BA
Core Evidence 2018, 13:1-12
Published Date: 24 January 2018
Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review
Beccari MV, Meaney CJ
Core Evidence 2017, 12:11-24
Published Date: 23 March 2017
Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy
Karagiannis T, Bekiari E, Tsapas A
Core Evidence 2017, 12:1-10
Published Date: 15 March 2017
Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy
Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R
Core Evidence 2016, 11:49-61
Published Date: 14 December 2016
Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy
Serratrice C, Carballo S, Serratrice J, Stirnemann J
Core Evidence 2016, 11:37-47
Published Date: 14 October 2016
Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy
Buti S, Leonetti A, Dallatomasina A, Bersanelli M
Core Evidence 2016, 11:23-36
Published Date: 1 September 2016
Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy
Margaritopoulos GA, Vasarmidi E, Antoniou KM
Core Evidence 2016, 11:11-22
Published Date: 1 July 2016
Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy
Angeloni E
Core Evidence 2016, 11:1-10
Published Date: 5 April 2016
Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review
Henrie AM, Nawarskas JJ, Anderson JR
Core Evidence 2015, 10:99-109
Published Date: 2 November 2015
Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis
Inomata M, Nishioka Y, Azuma A
Core Evidence 2015, 10:89-98
Published Date: 27 August 2015
Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy
Celio L, Niger M, Ricchini F, Agustoni F
Core Evidence 2015, 10:75-87
Published Date: 21 August 2015
An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillation
Acharya T, Deedwania P
Core Evidence 2015, 10:63-73
Published Date: 28 April 2015
Vilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapy
Hellerstein DJ, Flaxer J
Core Evidence 2015, 10:49-62
Published Date: 20 April 2015
Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based review
Kmeid J, Kanafani ZA
Core Evidence 2015, 10:39-47
Published Date: 11 February 2015
Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy
Dinnel J, Moore BL, Skiver BM, Bose P
Core Evidence 2015, 10:23-38
Published Date: 13 January 2015
Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes
Edwards KL, Minze MG
Core Evidence 2015, 10:11-21
Published Date: 9 January 2015
Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy
Graff JN, Chamberlain ED
Core Evidence 2015, 10:1-10
Published Date: 18 December 2014
Luliconazole for the treatment of fungal infections: an evidence-based review
Khanna D, Bharti S
Core Evidence 2014, 9:113-124
Published Date: 24 September 2014
Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy
Koerner-Rettberg C, Ballmann M
Core Evidence 2014, 9:99-112
Published Date: 19 September 2014
Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis
Coimbra S, Figueiredo A, Santos-Silva A
Core Evidence 2014, 9:89-97
Published Date: 21 July 2014
Regorafenib: an evidence-based review of its potential in patients with advanced liver cancer
Ravi S, Singal AK
Core Evidence 2014, 9:81-87
Published Date: 17 July 2014
Clinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review
Buckley MS, Berry AJ, Kazem NH, Patel SA, Librodo PA
Core Evidence 2014, 9:71-80
Published Date: 20 June 2014
Development of cabozantinib for the treatment of prostate cancer [Corrigendum]
Vaishampayan UN
Core Evidence 2014, 9:69-70
Published Date: 16 May 2014
Development of cabozantinib for the treatment of prostate cancer
Vaishampayan UN
Core Evidence 2014, 9:61-67
Published Date: 23 April 2014
Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential
Song SJ, Smiddy WE
Core Evidence 2014, 9:51-59
Published Date: 21 March 2014
Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]
Shah I, Khan SO, Malhotra S, Fischell T
Core Evidence 2014, 9:49-50
Published Date: 14 March 2014
Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis
Di Franco M, Gerardi MC, Lucchino B, Conti F
Core Evidence 2014, 9:41-48
Published Date: 12 March 2014
Micafungin: an evidence-based review of its place in therapy
de la Torre P, Reboli AC
Core Evidence 2014, 9:27-39
Published Date: 25 February 2014
Ceftazidime–avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections
Lagacé-Wiens P, Walkty A, Karlowsky JA
Core Evidence 2014, 9:13-25
Published Date: 24 January 2014
Targeted therapy in triple-negative metastatic breast cancer: a systematic review and meta-analysis
Clark O, Botrel TE, Paladini L, Ferreira MB
Core Evidence 2014, 9:1-11
Published Date: 6 January 2014
Lapatinib plus chemotherapy or endocrine therapy (CET) versus CET alone in the treatment of HER-2-overexpressing locally advanced or metastatic breast cancer: systematic review and meta-analysis
Botrel TE, Paladini L, Clark OA
Core Evidence 2013, 8:69-78
Published Date: 30 September 2013
Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
Schaller SJ, Fink H
Core Evidence 2013, 8:57-67
Published Date: 25 September 2013
Lixivaptan – an evidence-based review of its clinical potential in the treatment of hyponatremia
Bowman BT, Rosner MH
Core Evidence 2013, 8:47-56
Published Date: 11 July 2013
Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia
Chavez JC, Sahakian E, Pinilla-Ibarz J
Core Evidence 2013, 8:37-45
Published Date: 16 May 2013
Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer
Golshayan AR, Antonarakis ES
Core Evidence 2013, 8:27-35
Published Date: 4 April 2013
An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies
Goard CA, Schimmer AD
Core Evidence 2013, 8:15-26
Published Date: 14 March 2013
Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis
Botrel TEA, Clark O, Pompeo ACL, Bretas FFH, Sadi MV, Ferreira U, dos Reis RB
Core Evidence 2013, 8:1-13
Published Date: 7 March 2013
An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy
Watkins RR, Lemonovich TL, File Jr TM
Core Evidence 2012, 7:131-143
Published Date: 11 December 2012